
Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TWST | US
0.49
2.04%
Healthcare
Diagnostics & Research
30/09/2023
29/11/2023
24.51
24.29
25.61
24.01
Twist Bioscience Corporation a synthetic biology company manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products including synthetic genes tools for sample preparation antibody libraries for drug discovery and development and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. The company was incorporated in 2013 and is headquartered in South San Francisco California.
View LessPositive Momentum
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
No Dividends (Dividend Yield = 0%)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
136.8%1 month
113.8%3 months
85.9%6 months
77.9%0
0
1.90
0.15
0.12
-5.14
5.35
0
-181.06M
1.41B
1.41B
0
-74.81
0
16.80
-28.97
16.79
29.83
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
6.98
Range1M
11.35
Range3M
11.35
Rel. volume
1.52
Price X volume
42.64M